TRANSPHARMA INTERNATIONAL LIMITED
Get an alert when TRANSPHARMA INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£222
+362.5% highest in 3 filed years
Net assets
£7m
+13.6% highest in 3 filed years
Employees
26
0% vs 2024
Profit before tax
£1.4m
-8.8% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £28,168,463 | £26,220,837 | £21,701,859 | -17.2% | |
| Operating profit | £1,628,797 | £1,410,534 | £1,238,403 | -12.2% | |
| Profit before tax | £1,813,454 | £1,559,820 | £1,422,332 | -8.8% | |
| Net profit | £1,813,454 | £1,559,820 | £839,812 | -46.2% | |
| Cash | £0 | £48 | £222 | +362.5% | |
| Total assets less current liabilities | £4,607,525 | £6,167,345 | £7,007,157 | +13.6% | |
| Net assets | £4,607,525 | £6,167,345 | £7,007,157 | +13.6% | |
| Equity | £4,607,525 | £6,167,345 | £7,007,157 | +13.6% | |
| Average employees | 26 | 26 | 26 | 0% | |
| Wages | £1,124,687 | £1,104,709 | £1,054,755 | -4.5% | |
| Directors' remuneration | £195,137 | £107,986 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 5.8% | 5.4% | 5.7% | |
| Net margin | 6.4% | 5.9% | 3.9% | |
| Return on capital employed | 35.4% | 22.9% | 17.7% | |
| Gearing (liabilities / total assets) | — | 33.5% | 26.3% | |
| Current ratio | 2.46x | 2.96x | 3.78x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 4 times since incorporation
- TRANSPHARMA INTERNATIONAL LIMITED 2021-06-03 → present
- MOVIANTO TRANSPORT SOLUTIONS LIMITED 2011-05-09 → 2021-06-03
- HEALTHCARE LOGISTICS GROUP LIMITED 1997-10-16 → 2011-05-09
- HEALTHCARE SERVICES GROUP LIMITED 1997-09-09 → 1997-10-16
- CHARCO 465 LIMITED 1997-07-28 → 1997-09-09
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of the directors' assessment of the financial position of the company at the year end, they have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future and will be able to meet obligations as they fall due. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 30 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| A G SECRETARIAL LIMITED | Corporate Secretary | 2012-10-15 | — | — |
| EVANS, David Richard | Director | 2026-04-21 | Mar 1971 | British |
| JACQUES, Bruno | Director | 2025-12-10 | Dec 1974 | Belgian |
| MOVIANTO INTERNATIONAL B.V. | Corporate Director | 2025-12-10 | — | — |
Show 30 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOYLE, Sarah | Secretary | 2005-05-18 | 2006-01-20 |
| SHEPHERD, William | Secretary | 2011-08-01 | 2012-08-31 |
| SMERDON, Peter | Secretary | 2006-01-20 | 2011-08-01 |
| WHEATON, Anthony Peter | Secretary | 1997-09-05 | 1998-02-26 |
| WILSON, Graham | Secretary | 1998-02-26 | 2005-05-18 |
| BAYSHILL SECRETARIES LIMITED | Corporate Nominee Secretary | 1997-07-28 | 1997-09-05 |
| BOYLE, Sarah | Director | 2005-05-18 | 2007-10-01 |
| BRADFORD, Peter John | Director | 2007-02-19 | 2009-09-11 |
| CLARKE, Alan | Director | 2011-03-11 | 2014-03-31 |
| COLPO, Charles Craig | Director | 2014-12-15 | 2018-03-05 |
| EVANS, David Richard | Director | 2011-03-31 | 2024-10-15 |
| FALL, Alan James | Director | 1997-09-05 | 2007-03-02 |
| GLOOR, Charles Antoine | Director | 2005-05-18 | 2005-09-30 |
| GROENEVELD, Marinus | Director | 2014-03-21 | 2014-12-02 |
| HOWES, Alistair Matthew | Director | 2019-06-27 | 2020-06-18 |
| HUNJAN, Kamaljit Singh | Director | 2019-01-18 | 2020-06-18 |
| JAMES, Mark Litten | Director | 2014-12-15 | 2018-03-05 |
| LATTEUR, Benoit Francois | Director | 2024-10-15 | 2026-03-30 |
| MUNZINGER, Julia M. | Director | 2018-03-05 | 2019-06-27 |
| O'NEILL, Barbara | Director | 2018-03-05 | 2020-06-18 |
| PAASCH, Alexander | Director | 2008-11-04 | 2012-02-29 |
| ROBINSON, Tim David | Director | 2007-10-01 | 2010-05-14 |
| ROCHE, Conor | Director | 2005-09-30 | 2008-11-03 |
| SIEGEL, Robert | Director | 2014-03-21 | 2015-03-31 |
| WHEATON, Anthony Peter | Director | 1997-09-05 | 1998-02-26 |
| WILSON, Graham | Director | 1998-02-26 | 2005-05-18 |
| BAYSHILL MANAGEMENT LIMITED | Corporate Nominee Director | 1997-07-28 | 1997-09-05 |
| MOVIANTO HOLDING UK LIMITED | Corporate Director | 2020-06-18 | 2024-10-15 |
| TRANSPHARMA INTERNATIONAL HOLDING B.V. | Corporate Director | 2024-10-15 | 2025-05-23 |
| WALDEN GROUP INTERNATIONAL HOLDING B.V. | Corporate Director | 2025-05-23 | 2025-12-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nippon Yusen Kabushiki Kaisha | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors (as firm), Significant influence (as firm) | 2025-12-10 | Active |
| Stephane Jean-Francois Baudry | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-12-21 | Ceased 2025-12-10 |
| Healthcare Services Group Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2023-12-15 |
Filing timeline
Last 20 of 163 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-27 | AA | accounts | Accounts with accounts type full | |
| 2026-07-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-07-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-06-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-05-06 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-13 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-23 | AP02 | officers | Appoint corporate director company with name date | |
| 2025-12-23 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-12-23 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-06-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-23 | AP02 | officers | Appoint corporate director company with name date | |
| 2025-05-15 | AA | accounts | Accounts with accounts type full | |
| 2024-10-16 | AP02 | officers | Appoint corporate director company with name date | |
| 2024-10-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-20 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 11
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.